EliteEssentialFDA-lirLab Compliance AdvisorLaboratory Industry ReportNational Lab ReporterPremiumGail Dutton
FDA Proposal for LDTs Risks Serious Consequences
Lab leaders say that the increased level of scrutiny proposed for such tests would be a detriment to innovation and patient care.
